Basagan, Baby Girl .
HRN: 25-13-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/23/2024
05/29/2024
IV
37mg
OD
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes